New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2013
10:11 EDTCOH, TBBK, XONE, VRA, HMIN, ULTA, TIF, TJX, SIG, SBH, ROST, PNK, ONCY, KORS, HIIQ, GPS, FNP, PVAOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Coach (COH) initiated with a Buy at Sterne Agee.. Fifth & Pacific (FNP) initiated with a Buy at Sterne Agee... Gap (GPS) initiated with an Underperform at Sterne Agee... Health Insurance Innovations (HIIQ) initiated with a Buy at Citigroup... Michael Kors (KORS) initiated with a Neutral at Sterne Agee... Oncolytics Biotech (ONCY) initiated with an Overweight at Piper Jaffray... Pinnacle Entertainment (PNK) initiated with a Buy at BofA/Merrill... Ross Stores (ROST) initiated with a Neutral at Sterne Agee... Sally Beauty (SBH) initiated with a Buy at Sterne Agee... Signet Jewelers (SIG) initiated with a Neutral at Sterne Agee... TJX (TJX) initiated with a Buy at Sterne Agee... Tiffany (TIF) initiated with a Neutral at Sterne Agee... Ulta Salon (ULTA) initiated with a Buy at Sterne Agee... Vera Bradley (VRA) initiated with an Underperform at Sterne Agee... Home Inns (HMIN) initiated with an Outperform at Credit Suisse... ExOne (XONE) initiated with a Buy at BB&T... ExOne (XONE) initiated with an Outperform at FBR Capital... The Bancorp (TBBK) initiated with a Buy at BTIG... Penn Virginia (PVA) initiated with an Outperform at Wells Fargo.
News For COH;FNP;GPS;HIIQ;KORS;ONCY;PNK;ROST;SBH;SIG;TJX;TIF;ULTA;HMIN;VRA;XONE;TBBK;PVA From The Last 14 Days
Check below for free stories on COH;FNP;GPS;HIIQ;KORS;ONCY;PNK;ROST;SBH;SIG;TJX;TIF;ULTA;HMIN;VRA;XONE;TBBK;PVA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 11, 2014
09:13 EDTGPSOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Fastenal (FAST), up 3%... Wells Fargo (WFC), up 0.2%. ALSO HIGHER: H&R Block (HRB), up 5% after announcing a deal for BofI (BOFI) to acquire H&R Block's bank assets. Bofi up 9.4% after the deal announcement... Zynga (ZNGA), up 1.7% after naming new CFO, shares upgraded to Equal Weight at Morgan Stanley... SINA (SINA), up 2% after announcing up to $500M share repurchase program. DOWN AFTER EARNINGS: JPMorgan (JPM), down 3.7%... NQ Mobile (NQ), down 14.6%. ALSO LOWER: Gap (GPS), down 4% after reporting March SSS fell 6%, shares downgraded at Janney Capital... Voxeljet (VJET), down 16% after 3M share secondary offering priced at $15.00... Datawatch (DWCH), down 29% after cutting its second quarter revenue outlook.
08:12 EDTTIFTiffany announces General Counsel to retire
Subscribe for More Information
06:38 EDTGPSGap downgraded to Neutral from Buy at Janney Capital
Subscribe for More Information
06:29 EDTGPSGap downgraded to Neutral from Buy at Janney Capital
Subscribe for More Information
April 10, 2014
19:00 EDTGPSOn The Fly: After Hours Movers
NOTABLE: According to a Bloomberg report that cited sources, Kathleen Sebelius, U.S. Secretary of Health and Human Services, is set to resign tomorrow. A New York Times report added that President Obama is expected to nominate Sylvia Mathews Burwell, Director of the Office of Management and Budget, as Sebelius' replacement. HIGHER: Shares of BofI Holding (BOFI) and H&R Block (HRB) both advanced after announcing a deal for BofI to acquire H&R Block's bank assets. BofI, which saw shares gain 9% after hours, said it expects ongoing annual revenue from the deal of $26M-$28M beginning with its fiscal 2015. H&R Block, which gained 7%, said it expects the deal to be 7c-9c dilutive to earnings per share beginning in its fiscal 2015, and the company said it sees the deal resulting in $200M-$250M of immediate excess capital. LOWER: Gap (GPS), down 2.6% after reporting March same-store sales that fell 6% and saying that it expects first quarter gross margins to decline more when compared to the prior year period than they did in the preceding quarter... NQ Mobile (NQ), down 8.8% after reporting earnings that missed expectations on revenue that topped estimates and saying that it identified an accounting overstatement related to share-based compensation for the three and nine months ended September 30... Datawatch (DWCH), down 25% after cutting its second quarter revenue outlook... TTM Technologies (TTMI), down 3.9% after cutting its first quarter earnings outlook and saying it expects first quarter revenue to come in at the low end of its previous guidance range.
16:02 EDTGPSGap reaffirms FY14 EPS view $2.90-$2.95, consensus $2.96
As the company noted last month, the Easter holiday is in April this year versus March last year. Given this shift in peak spring selling weeks, the company expected March to be negatively impacted. The company expects gross margins for Q1 to be below the prior year by more than the year-over-year decline in Q4. In addition, given ongoing expense management, the company expects Q1 operating expenses to be flat to last year.
16:01 EDTGPSGap reports March SSS down 6%
Subscribe for More Information
14:26 EDTKORSMichael Kors volatility stays flat on wide price movement
Subscribe for More Information
07:24 EDTSIGCitigroup to hold a conference
Diamond Days Conference is being held in New York on April 10.
April 9, 2014
11:37 EDTHIIQHealth Insurance Innovations reports 107% Q1 sales growth
Health Insurance Innovations announced record sales results for the first quarter ended March 31. The total of 57,644 submitted applications received in the first quarter represents an increase of 107% over first quarter 2013, with 56% sequential growth from fourth quarter 2013 to first quarter 2014. Submitted applications represent the number of customer applications for all types of policies sold by HII and are a non-financial measure used by management to monitor and manage the success of company new policy sales.
10:33 EDTPNKBofA/Merrill's gaming analysts hold an analyst/industry conference call
Gaming Analysts provide an industry update and outlook on an Analyst/Industry conference call. Relevant covered companies LVS, WYNN, MGM, PENN, PNK, CZR, BYD and IGT may be discussed on the Analyst/Industry conference call to be held on April 15 at 10:30 am.
09:20 EDTTIFBofA/Merrill's retail analysts hold an analyst/industry conference call
Subscribe for More Information
April 8, 2014
09:00 EDTONCYOncolytics Biotech rises 12.4%
Subscribe for More Information
06:38 EDTONCYOncolytics Biotech reports tumor stabilization or shrinkage in REOLYSIN study
Oncolytics Biotech announced additional data from the Company's randomized, double-blinded clinical study examining REOLYSIN in combination with carboplatin and paclitaxel in patients with second-line, platinum-refractory, taxane-na´ve head and neck cancers, or REO 018. Highlights include: 118 patients had loco-regional head and neck disease, with or without distal metastases An intent-to-treat analysis of the overall survival, or OS, of the 118 patients with loco-regional disease was performed on all patients to the median PFS in each arm, censoring any patients who received post-discontinuation therapy at the date at which they commenced the first of these therapies. This analysis demonstrated a statistically significant improvement in OS for the test arm versus the control arm; and the 118 patients with loco-regional head and neck disease, with or without distal metastases, were evaluated for percentage magnitude of tumour shrinkage at the first post-treatment scan. The test arm showed a statistical trend towards better tumour stabilization or shrinkage over the control arm. There were 47 patients with distal metastases alone. At the time of the analysis, eight of the 47 patients were still alive. The test arm patients in this group maintained a PFS benefit over control arm patients for five cycles of therapy. There are too few patients to power a statistical analysis of the PFS and OS of this patient group; and the 47 patients with distal metastases alone were evaluated for percentage magnitude of tumour shrinkage at the first post-treatment scan (performed at approximately six weeks). The test arm demonstrated statistically significantly better tumour stabilization or shrinkage than the control arm.
06:37 EDTONCYOncolytics Biotech to host conference call
Conference call to discuss additional data analysis from the Company's REO 018 trial in head and neck cancers will be held on April 8 at 7:45 am. Webcast Link
06:35 EDTONCYOncolytics Biotech announces additional data from REO 018 study of Reolysin
Subscribe for More Information
April 7, 2014
12:04 EDTPVAPenn Virginia repeats FY14 revenue view $587M-$630M
Subscribe for More Information
07:43 EDTPVAIndependent Petroleum Association of America to hold a conference
Subscribe for More Information
07:31 EDTSIGZale, Signet Jewelers announce expiration of HSR Act waiting period
Subscribe for More Information
06:22 EDTXONE3-D stocks off to a rough start in 2014, WSJ reports
3-D stocks are off to a rough start this year with 3D Systems (DDD) down 40% and Stratasys (SSYS) down about 19%, the Wall Street Journal reports, but adds that some 3-D stocks remain priced at 50-70 times projected 2014 earnings. Reference Link
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use